AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

AtriCure, Inc. (ATRC) will be participating in the 23rd Annual Needham Virtual Healthcare Conference with a fireside chat on April 9, 2024, at 1:30 p.m. EST. The company is known for its innovative surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management. Interested parties can access the live webcast on the company's investor section website.

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming 23rd Annual Needham Virtual Healthcare Conference.

AtriCure’s management is scheduled to participate in a fireside chat on Tuesday, April 9, 2024, at 1:30 p.m. Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator^® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip^® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE^® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on X (formerly Twitter) @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240326746925/en/

Angie Wirick

AtriCure, Inc.

Chief Financial Officer

(513) 755-5334

awirick@atricure.com



Marissa Bych

Gilmartin Group

Investor Relations

marissa@gilmartinir.com

Source: AtriCure, Inc.

FAQ

When is AtriCure, Inc. participating in the 23rd Annual Needham Virtual Healthcare Conference?

AtriCure, Inc. (ATRC) is participating in the conference on April 9, 2024.

What time is the fireside chat scheduled for?

The fireside chat is scheduled for 1:30 p.m. Eastern Standard Time.

What is AtriCure, Inc. known for?

AtriCure, Inc. is known for its innovative surgical treatments for atrial fibrillation, left atrial appendage management, and post-operative pain management.

Where can interested parties access the live audio webcast?

Interested parties can access the live audio webcast on the 'Investors' section of AtriCure, Inc.'s website at https://ir.atricure.com.